Overview

Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
In this study, 66 HIV-infected women who desire contraception will be randomly assigned to use either an IUD or Depo Provera, and will be followed for six months. The study is intended to help investigators understand potential mechanisms by which hormonal contraception may hasten HIV disease progression.
Phase:
Phase 2
Details
Lead Sponsor:
University of Alabama at Birmingham
Treatments:
Contraceptive Agents
Copper
Medroxyprogesterone
Medroxyprogesterone Acetate